Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2025 Earnings Call Transcript February 17, 2026
Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $1.72, expectations were $1.62.
Operator: Thank you for holding. We sincerely appreciate your patience. Please stay on the line, and we will be back in a moment. Thank you for holding.
Operator: We look forward to talking with you soon. Please hold the line, and we will be right back with you.
Operator: Thank you for holding. We look...
